.:. Listes > Par auteur > Arock .:.

27 documents classés par : Date Titre Nom du premier auteur Type de documents Date de dépôt

1 - 2 - 3

Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. Valent P., Klion A. D., Horny H.-P., Roufosse F., Gotlib J., Weller P. F., Hellmann A., Metzgeroth G., Leiferman K. M., Arock M. et al J Allergy Clin Immunol (2012) epub ahead of print [hal-00684651 - version 1]

Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT Dubreuil P., Letard S., Ciufolini M., Gros L., Humbert M., Castéran N., Borge L., Hajem B., Lermet A., Sippl W. et al PLoS ONE 4, 9 (2009) e7258 [inserm-00423392 - version 1]

Phenotypic and genotypic characteristics of mastocytosis according to the age of onset. Lanternier F., Cohen-Akenine A., Palmerini F., Feger F., Yang Y., Zermati Y., Barète S., Sans B., Baude C., Ghez D. et al PLoS ONE 3, 4 (2008) e1906 [hal-00282484 - version 1]

Case-control cohort study of patients' perceptions of disability in mastocytosis. Hermine O., Lortholary O., Leventhal P. S., Catteau A., Soppelsa F., Baude C., Cohen-Akenine A., Palmérini F., Hanssens K., Yang Y. et al PLoS ONE 3, 5 (2008) e2266 [hal-00284181 - version 1]

Ex vivo and in vitro primary mast cells. Arock M., Le Nours A., Malbec O., Daëron M. Methods in molecular biology (Clifton, N.J.) 415 (2008) 241-54 [pasteur-00269312 - version 1]

H4 histamine receptor mediates optimal migration of mast cell precursors to CXCL12. Godot V., Arock M., Garcia G., Capel F., Flys C., Dy M., Emilie D., Humbert M. Journal of Allergy and Clinical Immunology 120, 4 (2007) 827-34 [hal-00282492 - version 1]

Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Valent P., Akin C., Escribano L., Födinger M., Hartmann K., Brockow K., Castells M., Sperr W.R., Kluin-Nelemans H.C., Hamdy N.A.T. et al European Journal of Clinical Investigation 37, 6 (2007) 435-53 [hal-00282493 - version 1]

Rapamycin inhibits growth and survival of D816V-mutated c-kit mast cells. Gabillot-Carré M., Lepelletier Y., Humbert M., de Sepuvelda P., Hamouda N. B., Zappulla J. P., Liblau R., Ribadeau-Dumas A., Machavoine F., Letard S. et al Blood 108, 3 (2006) 1065-72 [hal-00282505 - version 1]

Dexamethasone and IL-10 stimulate glucocorticoid-induced leucine zipper synthesis by human mast cells. Godot V., Garcia G., Capel F., Arock M., Durand-Gasselin I., Asselin-Labat M.L., Emilie D., Humbert M. Allergy 61, 7 (2006) 886-90 [hal-00282496 - version 1]

Referent d-dimer enzyme-linked immunosorbent assay testing is of limited value in the exclusion of thromboembolic disease: result of a practical study in an ED. Ray P., Bellick B., Birolleau S., Marx J.-S., Arock M., Riou B. American Journal of Emergency Medicine 24, 3 (2006) 313-8 [hal-00282499 - version 1]